Literature DB >> 988431

Human C-peptide. Part I: Radioimmunoassay.

W Beischer, L Keller, M Maas, E Scherfer, E F Pfeiffer.   

Abstract

Synthetic human C-peptide bearing a Tyrosine group at its amino end is labelled with 125iodine using chloramin T or hydrogen peroxide and lactoperoxidase. The results are compared applying both methods. Antiserum to synthetic human C-peptide (without Tyrosine) which was partially compared to rabbit albumin, is raised in guinea pigs and goats. Goats show to be superior to guinea pigs concerning antibody production. The so-called "hook effect" phenomenon is observed in setting up the standard curves for the radioimmunoassay. Monotonically decreasing standard curves are obtained on dilution of antiserum with a high antibody titer which was produced by repeated immunization in goats. Free C-peptide and C-peptide bound to antiserum are separated with the anxion exchange resin Amberlite. Using this separation technique we excluded unspecific binding of labelled C-peptide to protein fractions in serum of diabetics. The sensitivity of our radioimmunoassay is approx. 0.3 ng C-peptide/ml serum. Intra- and interassay variability are below 10%. Human proinsulin is the only substance found to crossreact with the antiserum.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 988431     DOI: 10.1007/bf01470462

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  Human C-peptide in normal and diabetic subjects.

Authors:  L G Heding; S M Rasmussen
Journal:  Diabetologia       Date:  1975-06       Impact factor: 10.122

2.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  A new phenomenon of usefulness in the radioimmunoassay of plasma adrenocorticotropic hormone.

Authors:  S Matsukura; C D West; Y Ichikawa; W Jubiz; G Harada; F H Tyler
Journal:  J Lab Clin Med       Date:  1971-03

4.  Apparent cooperativity in radioimmunoassay of human chorionic gonadotropin.

Authors:  B D Weintraub; S W Rosen; J A McCammon; R L Perlman
Journal:  Endocrinology       Date:  1973-04       Impact factor: 4.736

5.  Computer analysis of radioligand assay and radioimmunoassay data.

Authors:  D Rodbard; J E Lewald
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1970

6.  [On radio-immunologic determination of insulin in blood].

Authors:  F Melani; H Ditschuneit; K M Bartelt; H Friedrich; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1965-09-15

7.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

8.  Enzymatic iodination of polypeptides with 125I to high specific activity.

Authors:  J I Thorell; B G Johansson
Journal:  Biochim Biophys Acta       Date:  1971-12-28

9.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

10.  Identification of proinsulin and C-peptide in human serum by a specific immunoassay.

Authors:  F Melani; A H Rubenstein; P E Oyer; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

View more
  18 in total

1.  The endocrine pancreas of glucagon-and somatostatin-immunized rabbits. I. Light microscopy and immunohistochemistry.

Authors:  D Grube; A Jörns
Journal:  Cell Tissue Res       Date:  1991-08       Impact factor: 5.249

2.  Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Authors:  S Madsbad
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

3.  Characterization of insulin resistance in type I diabetes.

Authors:  W Kerner; I Navascués; T von Schrenck; R Fussgänger; P Arias; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1985-06-18

4.  Relation between the degree of initial metabolic decompensation and the duration of the remission phase in type I diabetes mellitus.

Authors:  U Vetter; E Heinze; E Kohne; W M Teller; E Kleihauer
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

5.  Human C-peptide. Part II: Clinical studies.

Authors:  W Beischer; E Heinze; L Keller; S Raptis; W Kerner; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1976-08-01

6.  [Human C-peptide. Part III: dynamics of secretion of beta-cells in adult diabetics following glibenclamide-glucose i.v. (human C-peptide III) (author's transl)].

Authors:  W Beischer; S Raptis; L Keller; M Maas; B Beischer; K Feilen; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1978-02-01

7.  [Relation between body fat distribution, insulin levels and glucose tolerance in obese females].

Authors:  H Hauner; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1988-03-01

8.  Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects.

Authors:  V Schusdziarra; D Grube; H Seifert; J Galle; H Etzrodt; W Beischer; O Haferkamp; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1983-07-15

9.  Severe chronic cephalic pancreatitis: use of partial duodenopancreatectomy with occlusion of the pancreatic duct in 289 patients.

Authors:  F P Gall; C Gebhardt; R Meister; H Zirngibl; M U Schneider
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

10.  [Therapeutic pancreatic duct occlusion in chronic pancreatitis: clinical, exocrine and endocrine consequences in a 12 month follow-up study].

Authors:  M U Schneider; G Lux; C Gebhardt; R Meister; J Pichl; G Heptner; H Knorr; T Rödle; S Domschke; W Domschke
Journal:  Langenbecks Arch Chir       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.